Quantification of Serum Free RNA as a Predictive Biomarker for the Response to Chemotherapy in Patients with Lung Cancer: A Pilot Study |
Um, Soo-Jung
(Department of Internal Medicine, Dong-A University College of Medicine)
Lee, Su-Mi (Department of Internal Medicine, Dong-A University College of Medicine) Lee, Soo-Keol (Department of Internal Medicine, Dong-A University College of Medicine) Son, Choon-Hee (Department of Internal Medicine, Dong-A University College of Medicine) Ko, Mee-Kyung (Department of Pathology, Dong-A University College of Medicine) Roh, Mee-Sook (Department of Pathology, Dong-A University College of Medicine) Lee, Ki-Nam (Department of Radiology and Thoracic, Dong-A University College of Medicine) Choi, Pil-Jo (Department of Cardiovascular Surgery, Dong-A University College of Medicine) |
1 | Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C, Beljanski M. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 1989;46:318-22. DOI ScienceOn |
2 | Gonzalez R, Silva JM, Sanchez A, Dominguez G, Garcia JM, Chen XQ, et al. Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significance. Ann Oncol 2000;11:1097-104. DOI |
3 | Sanchez-Cespedes M, Monzo M, Rosell R, Pifarre A, Calvo R, Lopez-Cabrerizo MP, et al. Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients. Ann Oncol 1998;9:113-6. DOI ScienceOn |
4 | Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 1999;59:67-70. |
5 | Reddi KK, Holland JF. Elevated serum ribonuclease in patients with pancreatic cancer. Proc Natl Acad Sci USA 1976;73:2308-10. DOI ScienceOn |
6 | Sueoka E, Sueoka N, Iwanaga K, Sato A, Suga K, Hayashi S, et al. Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction. Lung Cancer 2005;48:77-83. DOI ScienceOn |
7 | Rainer TH, Wong LK, Lam W, Yuen E, Lam NY, Metreweli C, et al. Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem 2003;49:562-9. DOI ScienceOn |
8 | Fox A, Gal S, Fisher N, Smythe J, Wainscoat J, Tyler MP, et al. Quantification of circulating cell-free plasma DNA and endothelial gene RNA in patients with burns and relation to acute thermal injury. Burns 2008;34: 809-16. DOI ScienceOn |
9 | Lo YM, Rainer TH, Chan LY, Hjelm NM, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000;46:319-23. |
10 | Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004;350:379-92. DOI ScienceOn |
11 | Boyle P, Gandini S, Gray N. Epidemiology of lung cancer: a century of great success and ignominious failure. In: Hansen HH. Textbook of Lung Cancer. London: Martin Dunitz; 2000. p. 13-25. |
12 | Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977;37:646-50. |
13 | Schmidt B, Engel E, Carstensen T, Weickmann S, John M, Witt C, et al. Quantification of free RNA in serum and bronchial lavage: a new diagnostic tool in lung cancer detection? Lung Cancer 2005;48:145-7. DOI ScienceOn |
14 | Chang CP, Chia RH, Wu TL, Tsao KC, Sun CF, Wu JT. Elevated cell-free serum DNA detected in patients with myocardial infarction. Clin Chim Acta 2003;327:95-101. DOI |
15 | Galeazzi M, Morozzi G, Piccini M, Chen J, Bellisai F, Fineschi S, et al. Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders. Autoimmun Rev 2003; 2:50-5. DOI ScienceOn |
16 | Laktionov PP, Tamkovich SN, Rykova EY, Bryzgunova OE, Starikov AV, Kuznetsova NP, et al. Extracellular circulating nucleic acids in human plasma in health and disease. Nucleosides Nucleotides Nucleic Acids 2004;23:879-83. DOI ScienceOn |
17 | Zhou H, Xu W, Qian H, Yin Q, Zhu W, Yan Y. Circulating RNA as a novel tumor marker: an in vitro study of the origins and characteristics of extracellular RNA. Cancer Lett 2008;259:50-60. DOI ScienceOn |
18 | Kopreski MS, Benko FA, Kwak LW, Gocke CD. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res 1999; 5:1961-5. |
19 | Silva JM, Dominguez G, Silva J, Garcia JM, Sanchez A, Rodriguez O, et al. Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin Cancer Res 2001;7:2821-5. |
20 | Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003;21: 3902-8. DOI ScienceOn |
21 | Lo KW, Lo YM, Leung SF, Tsang YS, Chan LY, Johnson PJ, et al. Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin Chem 1999;45:1292-4. |
22 | Wong SC, Lo SF, Cheung MT, Ng KO, Tse CW, Lai BS, et al. Quantification of plasma beta-catenin mRNA in colorectal cancer and adenoma patients. Clin Cancer Res 2004;10:1613-7. DOI ScienceOn |
23 | Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-16. DOI ScienceOn |
24 | Tong YK, Lo YM. Diagnostic developments involving cell-free (circulating) nucleic acids. Clin Chim Acta 2006;363:187-96. DOI |